Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
Background: Current ESC guidelines recommend the use of intra-coronary pressure guidewires for functional assessment of intermediate-grade coronary stenoses. Angiography-derived quantitative flow ratio (QFR) is a novel method of assessing these stenoses, and guiding percutaneous coronary intervention (PCI). Methods/Design: The PIONEER IV trial is a prospective, all-comers, multi-center trial, which will randomize 2,540 patients in a 1:1 ratio to PCI guided by angiography-derived physiology or usual care, with unrestricted use in both arms of the Healing-Targeted Supreme sirolimus-eluting stent (HT Supreme). The stent's fast, biologically healthy, and robust endothelial coverage allows for short dual-antiplatelet therapy (DAPT); hence the antiplatelet regimen of choice is 1-month DAPT, followed by ticagrelor monotherapy. In the angiography-derived physiology guided arm, lesions will be functionally assessed using on-line QFR, with stenting indicated in lesions with a QFR ≤0.80. Post-stenting, QFR will be repeated in the stented vessel(s), with post-dilatation or additional stenting recommended if the QFR<0.91 distal to the stent, or if the delta QFR (across the stent) is >0.05. Usual care PCI is performed according to standard clinical practice. The primary endpoint is a non–inferiority comparison of the patient-oriented composite endpoint (POCE) of all-cause death, any stroke, any myocardial infarction, or any clinically, and physiologically driven revascularization with a non–inferiority risk-difference margin of 3.2%, at 1-year post-procedure. Clinical follow-up will be up to 3 years. The PIONEER IV trial aims to demonstrate non–inferiority of QFR-guided PCI to usual care PCI with respect to POCE at 1-year in patients treated with HT Supreme stents and ticagrelor monotherapy. Clinical Trial Registration: ClinicalTrials.gov Unique Identifier: NCT04923191 Classifications: Interventional Cardiology
Coronary Angiography, Coronary Artery Disease/therapy, Drug-Eluting Stents, Humans, Percutaneous Coronary Intervention/methods, Prospective Studies, Stents, Ticagrelor/therapeutic use, Treatment Outcome
32-43
Hara, Hironori
05ad55ae-1f1d-466a-98e6-c47c58c8a070
Serruys, Patrick W.
98dfd61b-78fb-4f77-9995-7d9959332961
O'Leary, Neil
a2b9c6fd-6871-4eeb-be6d-356f45436d36
Gao, Chao
249a2c6e-cf9a-4463-bd78-0f2ad7a17a3a
Murray, Alicia
4b2d75f0-ac23-4822-a91d-a630679c7071
Breslin, Elaine
86c44a97-0b07-4d7d-bba7-d5b10d8ac774
Garg, Scot
f504ab90-e0d5-4567-9c49-0c6cf2137c74
Bureau, Christophe
3c6056d1-6e08-4f3b-b451-539f5aa234e0
Reiber, Johan HC
46a7a0a5-b007-4c23-9b3b-ca7e14bcb829
Barbato, Emanuele
50106486-a9cd-4c08-9ee7-74d049a9356d
Aminian, Adel
a7af9afb-d528-45cb-a61d-ecee14541243
Janssens, Luc
43a3def3-9012-420d-b5d7-367b7d94e9d6
Rosseel, Liesbeth
7bbf7b2b-b0f0-4c6b-aa2e-b703274a0a13
Benit, Edouard
8df377c5-4b71-437d-b2b5-d933ce0fe4a8
Campo, Gianluca
56959271-26a6-44d1-9aed-feedaf093b96
Guiducci, Vincenzo
932ac294-31c1-4f4c-8104-6ed50ed71cae
Casella, Gianni
d2fb56d9-cdd1-4103-8e14-377aa6d58282
Santarelli, Andrea
37c01e06-2ba5-4ebc-8bb9-495f46266cf2
Franzè, Alfonso
db7ad58b-5651-4a58-8414-8274e834b356
Diaz, Victor Alfonso Jimenez
cf2a24e4-fc94-47c8-928e-dc9699e316a3
Iñiguez, Andrés
0e6df809-f9ea-4c9e-bbd3-935777f0988e
Brugaletta, Salvatore
956be673-43db-4f33-a073-39dd56b5122f
Sabate, Manel
bde81ec6-7678-4971-bfd7-0147edfddee9
Amat-Santos, Ignacio J.
52f2aa1e-529d-47f1-b015-b307df18bc99
Amoroso, Giovanni
96681fd7-5194-4c73-b439-0e0c31703b40
Wykrzykowska, Joanna
7f1370a3-8611-4974-9ee6-762884244eb0
von Birgelen, Clemens
4e767009-460f-4acc-89fc-4c6273e165a8
Somi, Samer
6d54521e-95ff-4349-99a4-b58f98bcfcff
Liu, Tommy
35b86b40-f0e7-47e4-a5f0-3a02d322928a
Hofma, Sjoerd H.
7da72d95-e69f-4831-8f68-2f112f273f1a
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Trillo, Ramiro
0f9fabe4-cc53-45b8-9a36-21cba15ae399
Ocaranza, Raymundo
8d005bd1-4d1b-45fe-a038-c2ed07cacac5
Mathur, Anthony
eb09e07f-799e-4f7c-9dc9-40a6df249398
Smits, Pieter C.
6753fe48-844c-4707-90a7-c7a55e04c0f0
Escaned, Javier
69f3a60d-03f9-4763-bec0-80b02344367f
Baumbach, Andreas
c5cc2c9b-73d8-402e-8aaa-8b856da9f7f3
Wijns, William
e3677790-8809-4faf-ba5c-f9efb1a578d5
Sharif, Faisal
af411836-417d-4394-b913-b4b09002e66f
Onuma, Yoshinobu
3bae88ea-1afa-43b2-bbd0-a68d72d78662
PIONEER IV trial investigator
April 2022
Hara, Hironori
05ad55ae-1f1d-466a-98e6-c47c58c8a070
Serruys, Patrick W.
98dfd61b-78fb-4f77-9995-7d9959332961
O'Leary, Neil
a2b9c6fd-6871-4eeb-be6d-356f45436d36
Gao, Chao
249a2c6e-cf9a-4463-bd78-0f2ad7a17a3a
Murray, Alicia
4b2d75f0-ac23-4822-a91d-a630679c7071
Breslin, Elaine
86c44a97-0b07-4d7d-bba7-d5b10d8ac774
Garg, Scot
f504ab90-e0d5-4567-9c49-0c6cf2137c74
Bureau, Christophe
3c6056d1-6e08-4f3b-b451-539f5aa234e0
Reiber, Johan HC
46a7a0a5-b007-4c23-9b3b-ca7e14bcb829
Barbato, Emanuele
50106486-a9cd-4c08-9ee7-74d049a9356d
Aminian, Adel
a7af9afb-d528-45cb-a61d-ecee14541243
Janssens, Luc
43a3def3-9012-420d-b5d7-367b7d94e9d6
Rosseel, Liesbeth
7bbf7b2b-b0f0-4c6b-aa2e-b703274a0a13
Benit, Edouard
8df377c5-4b71-437d-b2b5-d933ce0fe4a8
Campo, Gianluca
56959271-26a6-44d1-9aed-feedaf093b96
Guiducci, Vincenzo
932ac294-31c1-4f4c-8104-6ed50ed71cae
Casella, Gianni
d2fb56d9-cdd1-4103-8e14-377aa6d58282
Santarelli, Andrea
37c01e06-2ba5-4ebc-8bb9-495f46266cf2
Franzè, Alfonso
db7ad58b-5651-4a58-8414-8274e834b356
Diaz, Victor Alfonso Jimenez
cf2a24e4-fc94-47c8-928e-dc9699e316a3
Iñiguez, Andrés
0e6df809-f9ea-4c9e-bbd3-935777f0988e
Brugaletta, Salvatore
956be673-43db-4f33-a073-39dd56b5122f
Sabate, Manel
bde81ec6-7678-4971-bfd7-0147edfddee9
Amat-Santos, Ignacio J.
52f2aa1e-529d-47f1-b015-b307df18bc99
Amoroso, Giovanni
96681fd7-5194-4c73-b439-0e0c31703b40
Wykrzykowska, Joanna
7f1370a3-8611-4974-9ee6-762884244eb0
von Birgelen, Clemens
4e767009-460f-4acc-89fc-4c6273e165a8
Somi, Samer
6d54521e-95ff-4349-99a4-b58f98bcfcff
Liu, Tommy
35b86b40-f0e7-47e4-a5f0-3a02d322928a
Hofma, Sjoerd H.
7da72d95-e69f-4831-8f68-2f112f273f1a
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Trillo, Ramiro
0f9fabe4-cc53-45b8-9a36-21cba15ae399
Ocaranza, Raymundo
8d005bd1-4d1b-45fe-a038-c2ed07cacac5
Mathur, Anthony
eb09e07f-799e-4f7c-9dc9-40a6df249398
Smits, Pieter C.
6753fe48-844c-4707-90a7-c7a55e04c0f0
Escaned, Javier
69f3a60d-03f9-4763-bec0-80b02344367f
Baumbach, Andreas
c5cc2c9b-73d8-402e-8aaa-8b856da9f7f3
Wijns, William
e3677790-8809-4faf-ba5c-f9efb1a578d5
Sharif, Faisal
af411836-417d-4394-b913-b4b09002e66f
Onuma, Yoshinobu
3bae88ea-1afa-43b2-bbd0-a68d72d78662